Kaiseraugst (CH), 21st April 2006
Intervet International and DSM Nutritional Products signed an agreement on
sale and purchase of the CRINA business. In 2005, CRINA, located in Gland,
Switzerland had annual sales of about EUR 6 million. CRINA is the pioneering
company in plant extracts used as feed additives. The company employs 19
people. CRINA is specialized in digestibility modulators based on blends of
essential oils. With the acquisition of CRINA DSM Nutritional Products will
further strengthen its position in animal nutrition and health ingredients.
Both parties have agreed not to disclose financial details from this deal.
Plant extracts is one of the ingredient classes with high growth potential. It
is increasingly used in poultry, swine and cattle feeds to stabilize the
intestinal micro-flora, thus promoting animal health and stimulating its
performance.
“We are very pleased about this acquisition, as it further enriches our
product range for the nutrition of animals. The CRINA products and brands are
an attractive platform for launching some of the products we have in the
pipeline” commented
Krijn Rietveld, Senior Vice President New Business Development, DSM
Nutritional Products.
Ruurd Stolp, President of Intervet, explains: “With CRINA, Intervet divests
the last part of its global feed additives business in its overall strategy to
focus on the core business of vaccines and pharmaceuticals to keep animals
healthy.”
Intervet International
Intervet, a business unit of Akzo Nobel, based in Boxmeer, the Netherlands,
with sales of EUR 1,094 million in 2005, is dedicated to research and
development, production and marketing of innovative animal health products.
Intervet's product range, for use in livestock, companion animals, poultry and
fish, includes vaccines, antiparasitics, anti-infectives, endocrine products
and other pharmaceutical specialties. Intervet operates globally with its own
marketing organizations. The company currently employs around 5,000 people.
For further company information please visit
www.intervet.com.
DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins,
carotenoids and other fine chemicals to the feed, food, pharmaceutical and
personal care industries. The company has sales of about EUR 2 billion and a
long tradition as a pioneer in the discovery of new products, new formulations
and attractive applications for all industry segments. For further company
information please visit
www.dsmnutritionalproducts.com.
DSM
DSM is active worldwide in nutritional and pharma ingredients, performance
materials and industrial chemicals. The company creates innovative products
and services that help improve the quality of life. DSM’s products are used in
a wide range of end markets and applications such as human and animal
nutrition and health, cosmetics, pharmaceuticals, automotive and transport,
coatings, housing and electrics & electronics (E&E). DSM’s strategy, named
Vision 2010 – Building on Strengths, focuses on accelerating profitable and
innovative growth of the company’s specialties portfolio. Market-driven
growth, innovation and increased presence in emerging economies are key
drivers of this strategy. The group has annual sales of over
EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the
global leaders in many of its fields. The company is headquartered in the
Netherlands, with locations in Europe, Asia, Africa and the Americas. More
information about DSM can be found at www.dsm.com
.
For more information:
DSM Nutritional Products
Dr. Thomas Breisach
Tel. +41 (61) 6888514
Fax +41 (61) 6873716
e-mail:
Thomas.Breisach@dsm.com
Forward-looking statements
This press release contains forward-looking statements. These statements are
based on current expectations, estimates and projections of DSM management and
information currently available to the company. The statements involve certain
risks and uncertainties that are difficult to predict and therefore DSM does
not guarantee that its expectations will be realized. Furthermore, DSM has no
obligation to update the statements contained in this press release.
